OBJECTIVE
To study the short and long term differences in outcome between patients > or =80 years of age and those < or =79 years of age who received intravenous recombinant tissue plasminogen activator (iv rt-PA) for acute stroke within the first 3 hours of symptom onset.
METHODS
We studied consecutive patients treated with iv rt-PA for acute stroke, with prospective follow up of up to 3 yea...